Biologic Therapy
Author:
- 1 September 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Infusion Nursing
- Vol. 35 (5) , 301-313
Abstract
Biologic therapy includes a diverse group of drugs that act directly on the immune system. Sometimes referred to as "targeted therapy," the biologics include cytokines and monoclonal antibodies. These agents can be genetically engineered versions of naturally occurring substances, or novel compounds used for the treatment of cancer and for nononcology diagnoses. This article provides information on the general types of biotherapy, an overview of how these drugs interact within the body, specific side effects, and nursing management.Keywords
This publication has 63 references indexed in Scilit:
- Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane moleculesNature Medicine, 2011
- Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicitiesSupportive Care in Cancer, 2011
- Cytokines in dermatology - A basic overviewIndian Journal of Dermatology, 2011
- Beyond chemotherapy: new agents for targeted treatment of lymphomaNature Reviews Clinical Oncology, 2010
- A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphomaBritish Journal of Cancer, 2010
- Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agentsBritish Journal of Pharmacology, 2010
- The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapyBritish Journal of Cancer, 2009
- Anti-CD20 monoclonal antibodies: historical and future perspectivesHaematologica, 2009
- Heat Shock Protein 27 as a New Therapeutic Target for Radiation Sensitization of Head and Neck Squamous Cell CarcinomaMolecular Therapy, 2009
- TNFα blockade in human diseases: Mechanisms and future directionsClinical Immunology, 2008